Daniel B. Bellissimo

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial”.

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00119-9

N/A

1.4DataRank · unranked

38 citations

Scott D. Rothenberger, Robert Feldman, Danielle Nance, Andrew D. Leavitt, Lynn Malec +23 more

Characterization of copy-number variants in a large cohort of patients with von Willebrand disease reveals a relationship between disrupted regions and disease type

Research and Practice in Thrombosis and Haemostasis(2023)10.1016/j.rpth.2023.102232

N/A

0DataRank · unranked

2 citations

Pamela A. Christopherson, Crystal L. Perry, Daniel B. Bellissimo, Sandra L. Haberichter, Gabe Haller +5 more

The challenges and opportunities of offering and integrating training in clinical molecular genetics and clinical cytogenetics: A survey of LGG Fellowship Program Directors

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101820

N/A

0DataRank · unranked

2 citations

Vimla S. Aggarwal, A. Bale, Daniel B. Bellissimo, Jessica K. Booker, Yang Cao +30 more